Tyler Nelson - Jun 9, 2022 Form 4 Insider Report for Vivakor, Inc. (VIVK)

Role: Chief Financial Officer
Signature: /s/ Tyler Nelson
Stock symbol: VIVK
Transactions as of: Jun 9, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/13/2022, 08:18 PM
Previous filing: Mar 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIVK	Stock Option to Purchase Common Stock	Award	$0	+918K		$0.00	918K	Jun 9, 2022	Common Stock	918K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 9, 2022, Vivakor, Inc. (the "Company") entered into an Executive Employment Agreement (the "Agreement") with Tyler Nelson. Pursuant to the Agreement, the Company granted Mr. Nelson a stock option to acquire 917,825 shares of the Company's common stock (the "Stock Option"). The Stock Option will vest over two years with 360,145 of the shares vesting immediately, 219,312 of the shares vesting three (3) months after issuance, and the remaining 338,368 of the shares vesting in equal quarterly installments over the remaining seven (7) quarters (48,338 for 6 quarters and 48,340 in the last quarter), with an exercise price equal to 100% of the fair market value on the date grant, and which expires ten (10) years after the date of grant.

Content

On June 9, 2022, Vivakor, Inc. (the "Company") entered into an Executive Employment Agreement (the "Agreement") with Tyler Nelson. Pursuant to the Agreement, the Company granted Mr. Nelson a stock option to acquire 917,825 shares of the Company's common stock (the "Stock Option"). The Stock Option will vest over two years with 360,145 of the shares vesting immediately, 219,312 of the shares vesting three (3) months after issuance, and the remaining 338,368 of the shares vesting in equal quarterly installments over the remaining seven (7) quarters (48,338 for 6 quarters and 48,340 in the last quarter), with an exercise price equal to 100% of the fair market value on the date grant, and which expires ten (10) years after the date of grant.